Dacarbazine/octreotate-lu-177-dota-tyr-3/streptozocinVarious toxicities: 6 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2016年 / 1617卷 / 1期
关键词：
D O I：
10.1007/s40278-016-20862-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：83 / 83
相关论文
共 50 条
  • [41] Treatment with 177Lu-DOTA-Tyr3-octreotate in patients with somatostatin receptor positive tumors.
    Kwekkeboom, DJ
    Kam, BL
    Bakker, WH
    Kooij, PP
    de Herder, WW
    Srinivasan, A
    Erion, JL
    Bugaj, JL
    Schmidt, MA
    de Jong, M
    Krenning, EP
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 34P - 34P
  • [42] Long-term toxicity of [177Lu-DOTA0,Tyr3]octreotate in rats
    Edgar J. Rolleman
    Eric P. Krenning
    Bert F. Bernard
    Monique de Visser
    Magda Bijster
    Theo J. Visser
    Marcel Vermeij
    Jan Lindemans
    Marion de Jong
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 219 - 227
  • [43] Tumoral fibrosis effect on the radiation absorbed dose of 177Lu-Tyr3-octreotate and 177Lu-Tyr3-octreotate conjugated to gold nanoparticles
    Azorin-Vega, E. P.
    Zambrano-Ramirez, O. D.
    Rojas-Calderon, E. L.
    Ocampo-Garcia, B. E.
    Ferro-Flores, G.
    APPLIED RADIATION AND ISOTOPES, 2015, 100 : 96 - 100
  • [44] Radiotherapeutic efficacy of [177Lu]-DOTA-Tyr3-octreotate in novel rat tumor models.
    Bugaj, JE
    Johnson, MA
    Chinen, LK
    Schmidt, MA
    Srinivasan, A
    De Jong, M
    Erion, JL
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 125P - 125P
  • [45] TUMOR RESPONSE AND SIDE EFFECTS AFTER [177Lu-DOTA,Tyr3]OCTREOTATE THERAPY IN RATS
    De Jong, M.
    Bernard, B.
    Breeman, W.
    Krenning, E.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S121 - S121
  • [46] Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate
    van Vliet, Esther I.
    van Eijck, Casper H.
    de Krijger, Ronald R.
    van Dijkum, Elisabeth J. Nieveen
    Teunissen, Jaap J.
    Kam, Boen L.
    de Herder, Wouter W.
    Feelders, Richard A.
    Bonsing, Bert A.
    Brabander, Tessa
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (11) : 1647 - 1653
  • [47] Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate
    Mattias Sandström
    Ulrike Garske
    Dan Granberg
    Anders Sundin
    Hans Lundqvist
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 212 - 225
  • [48] Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3] octreotate
    Teunissen, JJM
    Kwekkeboom, DJ
    Krenning, EP
    Krenning, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2724 - 2729
  • [49] Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model
    Schmitt, A
    Bernhardt, P
    Kölby, L
    Nilsson, O
    Ahlman, H
    Mäcke, H
    Forssell-Aronsson, E
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (02) : 292 - 293
  • [50] Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model
    Schmitt, A
    Bernhardt, P
    Nilsson, O
    Ahlman, H
    Kölby, L
    Maecke, HR
    Forssell-Aronsson, E
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (09) : 1542 - 1548
12345